SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJames Halstead Regulatory News (JHD)

Share Price Information for James Halstead (JHD)

Share Price is delayed by 15 minutes
Get Live Data
128.80    4.60 (3.70%)
Bid:
128.20
Ask:
129.60
Spread: 1.40 (1.092%)
Market Cap: £536.34m
JHD Live PriceLast checked at - London Stock Exchange

Intraday James Halstead Share Chart

Trading Update

4 Aug 2021 07:00

RNS Number : 4622H
James Halstead PLC
04 August 2021
 

 

 

4 August 2021

 

 

JAMES HALSTEAD PLC(the "Company")

Trading Update 

James Halstead plc, the commercial flooring manufacturer and international distributor, is providing the following trading update ahead of its results for the year to 30 June 2021.

 

Trading in the second half of year has been encouraging despite the ongoing uncertainties in the global marketplace and notwithstanding some of the travails noted below, the Company expects to report both turnover and pre-tax profit at record levels for the period.

 

Early indications in February that international freight was showing signs of improving, in terms of cost and availability, was short lived and the chaos of the closure of the Suez canal has been matched by the turmoil in China and in particular the port of Yantain which handles vast amounts of international freight. Consequently, there have been delays in the supply of goods and ongoing adverse shipping costs.

 

In the UK, the availability of basic raw materials has continued to threaten smooth production but more disruptive has been the effect of employee shortages due to absenteeism mostly a result of the self-isolation of employees exposed to the virus. The Radcliffe production site has consequently struggled to achieve full output for many months. Teesside production has fared much better and third-party sourced finished goods have performed admirably.

 

It is apparent that the entire market has faced production issues and several of our competitors have had to suspend production due to material shortages. To date, we have not curtailed output and we believe this has helped us gain market share. In addition, it seems clear to us that while flooring retailers were closed, due to lockdown restrictions, our commercial flooring offerings (particularly in luxury vinyl tile) were used increasingly and significantly in domestic settings. This was a result not only of our long-held pedigree as a reliable global supplier but also of contractors playing a bigger part in the product choice decision as retailers, and to an extent distributors, were closed. Another notable point was a big increase in online retailing of flooring where, again, our strong brands aided growth. Both factors contributed to our expansion in the domestic UK flooring market, where demand increased not just because of rising consumer spending on the home but also with the move to home/garden offices and home gyms. Most of our major markets have experienced these trends.

 

Many of our end users have been extensively disrupted over the last year with an obvious reduction in demand for new outlets and refurbishment across many sectors, with hospitality being the most obvious deficit. Against this were notable uplifts in healthcare and the provision of vaccine supply. To date, we have delivered flooring to several hundred significant covid-care / vaccination facilities across the globe including Latin America, South Africa as well as China, Mexico and Italy.

 

Our balance sheet remains robust and continues to be bolstered by solid cash balances.

 

The Company will announce its full results for the year to 30 June 2021 around the end of September 2021.

 

 

 

 

 

 

Enquiries:

James Halstead plc

Tel: 0161 767 2500

Mark Halstead, Chief Executive

Gordon Oliver, Finance Director

Hudson Sandler

Tel: 020 7796 4133

Nick Lyon / Nick Moore

Panmure Gordon (Nomad and Joint Broker)

Tel: 020 7886 2500

Dominic Morley

WH Ireland (Joint Broker)

Ben Thorne

 

Tel: 020 7220 1666

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTDKNBDPBKDQFK
Date   Source Headline
1st Dec 20177:00 amRNSAGM Statement
20th Oct 20173:00 pmRNSAnnual Report & Accounts
2nd Oct 20177:00 amRNSBoard Changes
2nd Oct 20177:00 amRNSPRELIMINARY ANNOUNCEMENT OF AUDITED RESULTS
14th Sep 201712:42 pmRNSNotice of Preliminary Results
14th Sep 20177:00 amRNSNotice of Preliminary Results
1st Aug 201710:43 amRNSTotal Voting Rights
1st Aug 20177:00 amRNSPre-Close Trading Statement
31st Jul 20175:53 pmRNSDirector/PDMR Shareholding
3rd Jul 20175:40 pmRNSTotal Voting Rights
3rd Jul 20175:37 pmRNSBlock listing Interim Review
23rd Jun 20174:12 pmRNSDirector/PDMR Shareholding
12th Jun 201712:54 pmRNSDirector/PDMR Shareholding
9th Jun 20175:37 pmRNSTotal Voting Rights
12th May 20175:29 pmRNSDirector/PDMR Shareholding
12th May 20173:59 pmRNSDirector/PDMR Shareholding
5th Apr 20172:36 pmRNSDirector/PDMR Shareholding
29th Mar 20177:00 amRNSInterim Results
6th Mar 20177:00 amRNSNotice of Results
30th Jan 20177:00 amRNSPre Close Trading Statement
13th Dec 201611:13 amRNSResult of AGM
2nd Dec 20167:00 amRNSAGM Statement
1st Dec 20167:00 amRNSTotal Voting Rights
1st Nov 201612:24 pmRNSTotal Voting Rights
21st Oct 20167:00 amRNSAnnual Financial Report
3rd Oct 20167:00 amRNSPRELIMINARY ANNOUNCEMENT OF AUDITED RESULTS
21st Sep 20167:00 amRNSNotice of Preliminary Results
15th Aug 20167:00 amRNSAdoption of Financial Reporting Standard (FRS) 101
1st Aug 20167:00 amRNSPre-Close Trading Statement
1st Jul 20163:41 pmRNSBlock listing Interim Review
31st Mar 20167:00 amRNSInterim Results
8th Mar 20167:00 amRNSNotice of Interim Results
1st Feb 20164:51 pmRNSTotal Voting Rights
1st Feb 20167:00 amRNSPre Close Trading Statement
3rd Dec 20155:20 pmRNSDirector/PDMR Shareholding
1st Dec 20152:45 pmRNSTotal Voting Rights
27th Nov 201512:00 pmRNSChairman's Statement to the Annual General Meeting
2nd Nov 201511:39 amRNSTotal Voting Rights
29th Oct 20154:44 pmRNSDirector/PDMR Shareholding
23rd Oct 20159:45 amRNSAnnual Financial Report & Notice of AGM
29th Sep 20157:00 amRNSFinal Results
18th Sep 20157:00 amRNSNotice of Preliminary Results
31st Jul 20157:00 amRNSTotal Voting Rights
29th Jul 20157:00 amRNSPre-Close Trading Statement
28th Jul 20156:00 pmRNSBlocklisting Interim Review
24th Jul 20155:00 pmRNSDirector/PDMR Shareholding
1st Jul 20157:00 amRNSChange of Adviser
3rd Jun 20157:00 amRNSTotal Voting Rights
31st Mar 20157:00 amRNSInterim Results
20th Mar 20154:31 pmRNSNotice of Results - Replacement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.